Clinical Trials for Breast Cancers

EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers

NCT ID: NCT07018505

This clinical trial is exploring a new method to help doctors assess whether breast cancer has been completely removed during surgery and to check if cancer has spread to nearby lymph nodes. The tr...

Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada

NCT ID: NCT06960291

The EXCEL Exercise Oncology Program is a clinical trial aimed at helping people living with cancer, including prostate, breast, colon, and lung cancers, to incorporate exercise into their daily liv...

Prediction of ICG for Skin Necrosis in Mastectomy With Immediate Reconstruction

NCT ID: NCT06956443

This clinical trial is studying the use of a special imaging technique called Indocyanine Green (ICG) to help predict skin problems after surgery for breast cancer. Specifically, it looks at how IC...

Partial Breast Re-irradiation for Breast Cancer

NCT ID: NCT06954623

This clinical trial is exploring a new treatment approach for women with breast cancer who have had a recurrence after previous radiation therapy. Specifically, the study is looking at the use of p...

Breast Cancer PET/CT Imaging With 68Ga-pAKTi

NCT ID: NCT06943313

A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer Patients

NCT ID: NCT06811870

This clinical trial is exploring the use of hyperbaric oxygen therapy as a treatment before surgery for women with certain types of breast cancer. Hyperbaric oxygen therapy involves breathing pure ...

Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer

NCT ID: NCT06606730

The OPT-PEMBRO trial is a clinical study aimed at understanding how long patients with triple-negative breast cancer can safely continue treatment with the drug pembrolizumab after showing a strong...

A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Triple-Negative and HER2+ Breast Cancer Patients

NCT ID: NCT06825975

This clinical trial is looking at how effective and safe hyperbaric oxygen therapy might be as a treatment before surgery for women with specific types of breast cancer, including triple-negative a...

A Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Hormone Receptor Positive Breast Cancer Patients

NCT ID: NCT06825949

This clinical trial is looking to see how effective and safe hyperbaric oxygen therapy is as a treatment for women with hormone receptor-positive breast cancer before they undergo surgery. Hyperbar...

Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel Analogs

NCT ID: NCT06819501

This clinical trial is studying the use of hyperbaric oxygen therapy as a potential treatment for patients experiencing nerve damage, known as peripheral neuropathy, after receiving certain breast ...

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT ID: NCT06805812

The PALMARES-2 study is looking at how well certain treatments work for patients with advanced hormone receptor-positive, HER2-negative breast cancer. Specifically, it focuses on patients who are r...

Tirzepatide Weight Loss for MRD+ Early Breast Cancer

NCT ID: NCT06517212

This clinical trial is studying a medication called tirzepatide to see if it can help people with early breast cancer who are also overweight or obese. The goal is to find out if losing weight with...

Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation

NCT ID: NCT03667417

This clinical trial is looking at how certain genetic changes, specifically mutations in the BRCA1 and BRCA2 genes, can increase the risk of developing breast and ovarian cancers. Researchers want ...